Panagora Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-102,140
| Closed | -$856K | – | 1274 |
|
|
2026
Q1 | $856K | Sell |
102,140
-120,575
| -54% | -$1.27M | ﹤0.01% | 744 |
|
|
2025
Q4 | $3.21M | Buy |
222,715
+15,942
| +8% | +$199K | 0.01% | 469 |
|
|
2025
Q3 | $2M | Buy |
206,773
+395
| +0.2% | +$3.49K | 0.01% | 526 |
|
|
2025
Q2 | $1.69M | Hold |
206,378
| – | – | 0.01% | 511 |
|
|
2025
Q1 | $1.48M | Sell |
206,378
-1,651
| -0.8% | -$12.3K | 0.01% | 586 |
|
|
2024
Q4 | $1.61M | Sell |
208,029
-1,393
| -0.7% | -$13.1K | 0.01% | 561 |
|
|
2024
Q3 | $2.2M | Buy |
209,422
+23,667
| +13% | +$289K | 0.01% | 524 |
|
|
2024
Q2 | $2.17M | Sell |
185,755
-114,359
| -38% | -$1.78M | 0.01% | 497 |
|
|
2024
Q1 | $6.32M | Buy |
300,114
+77,751
| +35% | +$1.38M | 0.03% | 298 |
|
|
2023
Q4 | $3.99M | Buy |
222,363
+5,184
| +2% | +$91.3K | 0.02% | 366 |
|
|
2023
Q3 | $3.57M | Buy |
217,179
+17,805
| +9% | +$323K | 0.02% | 374 |
|
|
2023
Q2 | $3.99M | Buy |
199,374
+81,387
| +69% | +$1.57M | 0.02% | 375 |
|
|
2023
Q1 | $2.23M | Buy |
+117,987
| New | +$2.61M | 0.01% | 544 |
|
|
2022
Q3 | – | Sell |
-97,428
| Closed | -$2.41M | – | 1530 |
|
|
2022
Q2 | $2.41M | Sell |
97,428
-24,531
| -20% | -$613K | 0.02% | 585 |
|
|
2022
Q1 | $4.05M | Buy |
121,959
+4,724
| +4% | +$131K | 0.02% | 465 |
|
|
2021
Q4 | $3.83M | Buy |
117,235
+23,229
| +25% | +$791K | 0.02% | 463 |
|
|
2021
Q3 | $3.94M | Buy |
94,006
+9,339
| +11% | +$336K | 0.02% | 486 |
|
|
2021
Q2 | $3.29M | Buy |
84,667
+61,032
| +258% | +$2.18M | 0.02% | 554 |
|
|
2021
Q1 | $806K | Buy |
23,635
+21,611
| +1,068% | +$922K | ﹤0.01% | 1118 |
|
|
2020
Q4 | $92K | Sell |
2,024
-56,265
| -97% | -$1.97M | ﹤0.01% | 1865 |
|
|
2020
Q3 | $1.6M | Sell |
58,289
-41,050
| -41% | -$1.34M | 0.01% | 735 |
|
|
2020
Q2 | $3.66M | Buy |
99,339
+63,073
| +174% | +$2.35M | 0.02% | 482 |
|
|
2020
Q1 | $1.17M | Sell |
36,266
-107,651
| -75% | -$4.49M | 0.01% | 790 |
|
|
2019
Q4 | $5.9M | Buy |
143,917
+78,868
| +121% | +$3.12M | 0.03% | 447 |
|
|
2019
Q3 | $2.32M | Buy |
+65,049
| New | +$2.64M | 0.01% | 687 |
|
|
2019
Q2 | – | Sell |
-8,249
| Closed | -$473K | – | 2661 |
|
|
2019
Q1 | $473K | Hold |
8,249
| – | – | ﹤0.01% | 1413 |
|
|
2018
Q4 | $346K | Buy |
+8,249
| New | +$484K | ﹤0.01% | 1446 |
|
|
2018
Q2 | – | Sell |
-1,242
| Closed | -$37K | – | 2409 |
|
|
2018
Q1 | $37K | Sell |
1,242
-42
| -3% | -$1.22K | ﹤0.01% | 2111 |
|
|
2017
Q4 | $43K | Sell |
1,284
-17,425
| -93% | -$525K | ﹤0.01% | 2078 |
|
|
2017
Q3 | $616K | Hold |
18,709
| – | – | ﹤0.01% | 1284 |
|
|
2017
Q2 | $370K | Buy |
+18,709
| New | +$362K | ﹤0.01% | 1446 |
|
Other funds holding RGNX
RG
Panagora Asset Management's RGNX Position: Q2 2026 in Review
Panagora Asset Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 102,140 shares — an estimated $856K sold.
Panagora Asset Management first reported a position in RGNX in Q2 2017 and held it in 31 quarters. The position peaked at $6.32M in Q1 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Panagora Asset Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
- Panagora Asset Management sold 102,140 Regenxbio shares in Q2 2026, an estimated $856K.
- Panagora Asset Management first reported a position in Regenxbio in Q2 2017 and held it in 31 quarters.
- Panagora Asset Management's Regenxbio position peaked at $6.32M in Q1 2024.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.